Concepedia

Publication | Closed Access

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial

DOI

336

Citations

18

References

2019

Year

Bernard Zinman, Vaishali Bhosekar, Robert S. Busch, Ingrid Holst, Bernhard Ludvik, Desirée Thielke, James Thrasher, Vincent Woo, Athena Philis‐Tsimikas
The Lancet Diabetes & Endocrinology

References

YearCitations

Page 1